Entheon Biomedical Financial Stock Review: DMT-based psychedelic products to save lives: $ENBI.CN

Entheon Biomedical Financial Stock Review: DMT-based psychedelic products to save lives: $ENBI.CN ////

Let me show you how to sift through Entheon Biomedical’s income statement and statement of cash flows to understand their financials really well. We can run my discounted cash flow model together to see if the stock is a buy or a sell. We are also analyzing the financial ratios to see how they compare to their competitors. We will look at the debt of the company and equity. We will also calculate the WACC (weighted average cost of capital) so we can discount the future cash flows. Let's also look to see if the company is paying a dividend. If they are paying a dividend let's look at the historical dividend payments and try to figure out if they can maintain them in the future. Entheon Biomedical's stock price may be hard to estimate but maybe can figure it out together. Entheon Biomedical is an Biotechnology company that may be a great addition to your portfolio.

0:00 Opening
0:28 High Level Company Detail
1:38 Financial Review
3:58 Capital Structure
4:09 More info
5:20 Financial Ratios
6:27 Competitor Analysis
6:58 Closing

This video was conducted on behalf of Entheon Biomedical, and was funded by Gold Standard Media LLC and/or affiliates. For our full disclaimer, please visit:

CSE: ENBI | OTCQB: ENTBF

SUBSCRIBE:
Please subscribe to my channel:

MEMBERSHIP LEVELS:
If you'd like me to do a: (i) custom valuation for a stock of your choice for $9.99 per month or (iii) show your support for this channel for $0.99 per month, you can become a member by clicking on the link below:

MORE STOCK VIDEOS:

CONTACT:

I built this website to help small businesses value their company:

Discounted cash flow (DCF) is a valuation method used to estimate the value of an investment based on its future cash flows. DCF analysis attempts to figure out the value of an investment today, based on projections of how much money it will generate in the future.

This video is not intended to be investment advice. Seek a duly licensed professional for investment advice. I'm just a lowly mathematician!

[crawfordviolin]

Buying unestablished medical companies is super risky. I actually do buy actively managed medical mutual funds since it’s hard to keep up on all the news, new drugs, and the health of these companies. I do a little bit of everything, mostly actively managed in that sector, but also medical etfs, and some single stocks of the most established in the crowd.